Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Leukemia & Lymphoma Society’s Dare to Dream project helps pediatric cancer patients like Cayden, who received CAR-T therapy.
New research by Dana-Farber scientists looks at elevated body mass index and chemotherapy for acute lymphoblastic leukemia (ALL).
Immunotherapy drug Blincyto extends life for those with acute lymphoblastic leukemia (ALL) in remission
Research at #ASH22 calls into question longstanding assumptions and charts a path for gentler therapies.
What’s more, receiving SNAP benefits was not enough to address food insecurity for many families of children with leukemia, a study found.
Age, sex and decade of diagnoses influenced long-term survival of adolescent and young adult leukemia survivors.
Minimal residual disease status may not be as strong a predictor of relapse in Latino children.
Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.
Studies point to strategies to reduce disparities, improve outcomes and support shared decision-making.
Half of patients treated with the customized T cells achieved complete remission.
For Childhood Cancer Awareness Month, the National Cancer Institute’s Director Dr. Ned Sharpless reflects on childhood cancer progress.
Here’s a list of approved drugs to treat leukemia including acute lymphocytic or lymphoblastic leukemia (ALL), chronic lymphocytic le...
A probability approach uncovers gene expression changes in acute lymphoblastic leukemia, the most common form of cancer in children.
After being diagnosed with acute lymphoblastic leukemia, 7 year-old Ryan was officially declared in remission in April 2019.
New NCCN Guidelines for Patients: Pediatric Acute Lymphoblastic Leukemia offers a comprehensive look at the latest expert recommendations.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.